7Q DELETION/MONOSOMY (MDS) / HEPARIN BLOOD

image not found

NABL Cap Accredited 
The 7q Deletion/Monosomy (MDS) Test using heparinized blood at Metropolis Healthcare detects the deletion of the long arm of chromosome 7 in myelodysplastic syndromes (MDS). This chromosomal abnormality helps determine the subtype and risk of MDS. Identifying the 7q deletion is crucial for predicting disease progression and guiding treatment decisions. The test provides insights into prognosis and therapy response. It supports personalized care and monitoring of bone marrow disorders.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 5,195.00

Sample Type: HEPARIN BLOOD

Fasting Not Required


Booking Procedure:
  1. Technician from Metropolis will be assigned for a free home sample collection after booking confirmation.
  2. Sample will be collected by our technician at your address at given slot.
  3. You will get a payment link in 2 hours. You can make the payment online or pay cash to the technician.
  4. Soft copy reports will be sent to your email address within 24 to 48 hours.

Frequently Asked Questions (FAQ's):

1. What is the 7q Deletion/Monosomy (MDS) Test using heparinized blood?
This test detects the deletion of the long arm of chromosome 7 in patients with MDS using a heparin-treated blood sample for accurate analysis.

2. Why is this test important?
It helps assess disease progression, classify the MDS subtype, and guide personalized treatment plans.

3. Who should undergo this test?
Patients with diagnosed or suspected MDS or bone marrow disorders may be advised to take this test.

4. How is the test performed?
At Metropolis Healthcare, a heparinized blood sample is collected and analyzed using advanced cytogenetic techniques for precise detection.

5. What do the results indicate?
Detection of 7q deletion provides information about prognosis, disease subtype, and treatment response, while absence suggests other variants of MDS.

6. Are there any risks associated with the test?
The test is safe, with minimal risk related to blood sample collection.

7. Why choose Metropolis Healthcare for this test?
Metropolis Healthcare offers reliable cytogenetic testing with advanced technology and expert analysis for effective monitoring and management of MDS.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab